These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 24880102)

  • 1. Reversal of target-specific oral anticoagulants.
    Siegal DM; Cuker A
    Drug Discov Today; 2014 Sep; 19(9):1465-70. PubMed ID: 24880102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Managing target-specific oral anticoagulant associated bleeding including an update on pharmacological reversal agents.
    Siegal DM
    J Thromb Thrombolysis; 2015 Apr; 39(3):395-402. PubMed ID: 25586208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How I treat target-specific oral anticoagulant-associated bleeding.
    Siegal DM; Garcia DA; Crowther MA
    Blood; 2014 Feb; 123(8):1152-8. PubMed ID: 24385535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Monitoring options and reversal agents for oral anticoagulants].
    Thorup SB; Husted SE; Vang ML
    Ugeskr Laeger; 2014 Apr; 176(9):. PubMed ID: 25096568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specific antidotes against direct oral anticoagulants: A comprehensive review of clinical trials data.
    Tummala R; Kavtaradze A; Gupta A; Ghosh RK
    Int J Cardiol; 2016 Jul; 214():292-8. PubMed ID: 27082776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticoagulation reversal in the era of the non-vitamin K oral anticoagulants.
    Enriquez A; Lip GY; Baranchuk A
    Europace; 2016 Jul; 18(7):955-64. PubMed ID: 25816811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measurement and reversal of the direct oral anticoagulants.
    Samuelson BT; Cuker A
    Blood Rev; 2017 Jan; 31(1):77-84. PubMed ID: 27625113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversal of anticoagulants: an overview of current developments.
    Greinacher A; Thiele T; Selleng K
    Thromb Haemost; 2015 May; 113(5):931-42. PubMed ID: 25832311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Managing bleeding and emergency reversal of newer oral anticoagulants: a review for primary care providers.
    Peacock WF
    Hosp Pract (1995); 2014 Oct; 42(4):75-82. PubMed ID: 25502131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How can we reverse bleeding in patients on direct oral anticoagulants?
    Crowther M; Cuker A
    Kardiol Pol; 2019; 77(1):3-11. PubMed ID: 30338501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A review of oral anticoagulants, old and new, in major bleeding and the need for urgent surgery.
    Milling TJ; Ziebell CM
    Trends Cardiovasc Med; 2020 Feb; 30(2):86-90. PubMed ID: 30952383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment with inhibitors of new oral direct anticoagulants in patients with severe bleedings or urgent surgical procedures. The new dabigatran antidote: the place of idarucizumab in clinical practice].
    Boda Z
    Orv Hetil; 2016 Mar; 157(12):443-50. PubMed ID: 26971644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Reversal strategies for non-vitamin K antagonist oral anticoagulants].
    Larsen FU; Hvas AM; Grove EL
    Ugeskr Laeger; 2016 Oct; 178(40):. PubMed ID: 27697119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversal of oral anticoagulation in patients with acute intracerebral hemorrhage.
    Kuramatsu JB; Sembill JA; Huttner HB
    Crit Care; 2019 Jun; 23(1):206. PubMed ID: 31171018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emergency reversal of anticoagulation: novel agents.
    Levine M; Goldstein JN
    Curr Neurol Neurosci Rep; 2014 Aug; 14(8):471. PubMed ID: 24969622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Latest advances in the reversal strategies for direct oral anticoagulants.
    Escal J; Lanoiselée J; Poenou G; Zufferey P; Laporte S; Mismetti P; Delavenne X
    Fundam Clin Pharmacol; 2024 Aug; 38(4):674-684. PubMed ID: 38350629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Warfarin and Newer Agents: What the Oral Surgeon Needs to Know.
    Steed MB; Swanson MT
    Oral Maxillofac Surg Clin North Am; 2016 Nov; 28(4):515-521. PubMed ID: 27624772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of agents for reversing the effects of target-specific oral anticoagulants.
    Riley TR; Gauthier-Lewis ML; Sanchez CK; Douglas JS
    Am J Health Syst Pharm; 2017 Jan; 74(2):54-61. PubMed ID: 27895055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. When and How to Use Reversal Agents for Direct Oral Anticoagulants?
    Gómez-Outes A; Suárez-Gea ML; Lecumberri R
    Curr Cardiol Rep; 2023 May; 25(5):371-380. PubMed ID: 36976497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical perspectives on the management of bleeding in patients on oral anticoagulants: the DECOVER Study (DElphi Consensus on oral COagulation and therapy action reVERsal)].
    Vicente V; Martín A; Lecumberri R; Coll-Vinent B; Suero C; González-Porras JR; Marco P; Mateo J; Roldán V; Soulard S; Crespo C; Camats M;
    Emergencias; 2017 Feb; 29(1):18-26. PubMed ID: 28825264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.